Bayesian multi-study non-negative matrix factorization for mutational signatures

Mutational signatures are typically identified from tumor genome sequencing data using non-negative matrix factorization (NMF). However, existing NMF techniques only decompose a single dataset, limiting rigorous comparisons of signatures across conditions. We propose a Bayesian NMF method that jointly decomposes multiple datasets to identify signatures and their sharing pattern across conditions. We propose a fully unsupervised "discovery-only" model and a semi-supervised "recovery-discovery" model that simultaneously estimates known and novel signatures, and extend both to estimate covariate effects. We demonstrate our approach on extensive simulations, and apply our method to answer questions related to colorectal cancer and early-onset breast cancer.

Authors

Institutions

Publication Details

Journal
Genome biology
Published
2025-04-16
DOI
https://doi.org/10.1186/s13059-025-03563-0
Citations
1
Primary Topic
Gene expression and cancer classification
Type
article
Field-Weighted Citation Impact
0.81

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bayesian multi-study non-negative matrix factorization for mutational signatures

Isabella N. Grabski, Giovanni Parmigiani, Lorenzo Trippa
1 citations
Genome biology
Gene expression and cancer classification
0.81
article

Bayesian multi-study non-negative matrix factorization for mutational signatures

Isabella N. Grabski, Giovanni Parmigiani, Lorenzo Trippa
article en
1 citations

Abstract

Mutational signatures are typically identified from tumor genome sequencing data using non-negative matrix factorization (NMF). However, existing NMF techniques only decompose a single dataset, limiting rigorous comparisons of signatures across conditions. We propose a Bayesian NMF method that jointly decomposes multiple datasets to identify signatures and their sharing pattern across conditions. We propose a fully unsupervised "discovery-only" model and a semi-supervised "recovery-discovery" model that simultaneously estimates known and novel signatures, and extend both to estimate covariate effects. We demonstrate our approach on extensive simulations, and apply our method to answer questions related to colorectal cancer and early-onset breast cancer.

Genome biologyVol. 26(1)
Dana-Farber Cancer Institute (US), Dana-Farber/Harvard Cancer Center (US), New York Genome Center (US)
National Science Foundation, Foundation for the National Institutes of Health
Openalex Percentile: Top 29%
Gene expression and cancer classification
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.